Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
Use this XERS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the XERS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the XERS SEC filings page. Lician reads the product cache first so this HTML stays unique to Xeris Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full XERS income, balance, and cash tables.